Morena D’Alise

Company: Nouscom

Job title: Head of Preclinical & Clinical Immunology

Seminars:

How do Viral Vectored Vaccines Targeting Tumour Neoantigens Elicit Potent & Effective Anti-tumour Immune Response? 9:30 am

Developing a potent heterologous prime/boost immunisation approach based on viral vectors (non-human Great Ape Adenovirus and MVA) encoding an unprecedented number of tumour neoantigens Demonstrating induction of strong and high-quality T cell immune response in patients Interrogating the intra-tumoural TCR repertoire to dissect the contribution of vaccine-induced T cells to clinical responsesRead more

day: Conference Day Two